Author

Antonio Esposito

IRCCS Ospedale San RaffaeleORCID 0000-0002-1170-6266Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Approach:genetic perturbation / CRISPR· 1

Frequent Co-Authors

Tamara CanuiD· 2 shared A. S. H. Costa· 1 shared Agostina Di PizioiD· 1 shared Alessandra BolettaiD· 1 shared Angela BachiiD· 1 shared Angelo D’AlessandroiD· 1 shared Angelo IannielliiD· 1 shared Christian FrezzaiD· 1 shared

Activity by Year

2024-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 31 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBioengineering

Tamara CanuORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

BioengineeringbioRxivPreprintNov 12, 2025

Targeted and efficient AAV therapy for neuroblastoma via direct capsid-antibody coupling

Mirko Luoni, Serena Gea Giannelli, Stefano Parracino…·Vania Broccoli

This paper develops AAV-STITCH, a method to target neuroblastoma cells using anti-GD2 ScFv coupled to AAV capsids, showing selective transduction and tumor suppression in mouse models.

1 citation

mouseexperimental assay

𝕏 PostBluesky

BiochemistryEMBO Molecular MedicinePeer-reviewedApr 29, 2024

Inhibition of Asparagine Synthetase Effectively Retards Polycystic Kidney Disease Progression

Sara Clerici, Christine Podrini, Davide Stefanoni…·Alessandra Boletta

This study shows that inhibiting asparagine synthetase (ASNS) with antisense oligonucleotides reduces kidney volume and improves renal function in PKD mice by targeting metabolic pathways.

22 citationstop 4%

mousebulk RNA-seq

𝕏 PostBluesky